| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 05/15/2008 | US20080113974 Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | US20080108827 Reacting 4-trifluoromethoxyaniline with ammonium thiocyanate; amyotrophic lateral sclerosis; simple, efficient, inexpensive, ecofriendly, robust, and readily scaleable |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108671 Non-systemic control of parasites |
| 05/08/2008 | US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 05/08/2008 | US20080108606 Side effect reduction; antiproliferative agents; schizophrenia |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/07/2008 | CN101176037A Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 05/07/2008 | CN101172930A 2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives |
| 05/07/2008 | CN101172162A Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 04/30/2008 | EP1916527A1 Analysis of mass spectral data in the quiet zones |
| 04/30/2008 | EP1915384A1 A method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008047655A1 Urea derivative for use in quantification of hydrogen peroxide |
| 04/24/2008 | WO2008006979B1 Process for preparing diaminophenothiazinium compounds |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080093987 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/23/2008 | EP1812412B1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/17/2008 | WO2008044095A1 Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/08/2008 | US7354915 as agonist; treatment of uterine fibroids, endometriosis, dysmenorrhea; anticarcinogenic: breast, uterine, ovarian, prostate cancers and meningioma; hormone replacement therapy; menopausal and post-menopausal hormone replacement therapy; skin disorders |
| 04/08/2008 | CA2393258C Phenothiazines in prill form |
| 04/03/2008 | US20080081906 cefdinir intermediate |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081802 Thiazolyl-Dihydro-Indazole |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 03/27/2008 | US20080074045 Organic electroluminescence device |
| 03/26/2008 | CN100376560C New tricyclic compounds and their use as medicine, process for their preparation and pharmaceutical compositions containing them |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2008 | US7344823 Transient optical state change materials useful in copy-protected compact discs |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080062838 Materials for optical medium copy-protection transiently reacting to a reader beam |
| 03/11/2008 | US7342009 Cyclic sulfonamides for inhibition of gamma-secretase |
| 03/06/2008 | US20080058321 Benzothiazin-3-one compound and intermediate therefor |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | WO2008007074A3 Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| 02/28/2008 | WO2008006979A3 Process for preparing diaminophenothiazinium compounds |
| 02/28/2008 | US20080051578 Substituted biaryls, process for their manufacture and use thereof as medicaments |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/27/2008 | CN101133040A Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 02/26/2008 | US7335652 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045515 To treat Alzheimer's disease; compounds with an additional fused ring containing an SO2 group; to suppress or attenuate the secretion of beta -amyloid; (4aSR,6RS,8aSR)-6-[(4-chlorophenyl)sulfonyl]-6-(2,5-difluorophenyl)-3-ethyloctahydro-1H-2,1,3-benzothiadiazine 2,2-dioxide; cyclization, alkylation |
| 02/21/2008 | US20080045513 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1888120A2 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080038840 Fluorescent Method And Compounds To Monitor Protein-Lipid Binding |
| 02/13/2008 | EP1638951B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033169 Crystalline Form Of Cefdinir Ammonium Salt As An Intermediate For The Preparation Of Pure Cefdinir |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/06/2008 | CN100366615C Reactive materials for limited play optical devices and methods of making same |
| 02/05/2008 | US7326506 Bridged charge transport materials having a central sulfur atom linkage |
| 01/31/2008 | US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/29/2008 | US7323563 Hydroxamic acid derivatives as antibacterials |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | WO2008007074A2 Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| 01/17/2008 | WO2008006979A2 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657535A1 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | CA2657352A1 Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| 01/10/2008 | WO2008005451A2 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | WO2007050425A3 Lxr modulators |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080009486 6-chloro-2'-(3-chlorophenyl)-4'-(2,2-dimethylpropyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione; mdm2 antagonists; have effects in p53 mutant cells by mdm2-p53 feedback control loop; anticarcinogenic agent; |
| 01/10/2008 | US20080007840 Optical apparatus and methods for chemical analysis |
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/03/2008 | US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof |
| 01/02/2008 | EP1872173A1 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 01/02/2008 | EP1871379A2 Cyanoarylamines |
| 01/02/2008 | CN101098877A Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/01/2008 | US7314932 Methods for minimizing thioamide impurities |
| 12/27/2007 | US20070298968 2,4,6-Phenyl-Substituted Cyclic Ketoenols |